Influence of Iyengar Yoga on the Bio-functional Age of Postmenopausal Women (IIYBFAPW)

A Single-center, Randomized, Controlled, Open-labelled, Two-armed, Interventional Clinical Trial Investigating the Effect of a 12 Week Iyengar Yoga Intervention on the Bio-functional Age of Postmenopausal Women.

The purpose of this Study is to find out if Iyengar-Yoga has a rejuvenating effect on women after menopause. The biofunctional status of the study participants will be assessed before and after a 12-week yoga program.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Postmenopausal women qualifying as participants for the study are patients at the Universitätsklinik für Frauenheilkunde in Bern or are recruited through public advertisement. After giving informed consent the patients will be screened for inclusion and exclusion criteria and their biofunctional Status will be assessed. The participants of the study will then be randomly assigned to the intervention group (12 week yoga program) or to the control group. In addition to the 90 minutes yoga sessions instructed by a professional yoga teacher, the participants of the intervention group are asked to perform two yoga sessions lasting 45 minutes per week at home and document these in a diary.

After the 12 weeks the biofunctional Status of all participants of the study will be reassessed.

Study Type

Interventional

Enrollment (Anticipated)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Berne, Switzerland, 3010
        • Recruiting
        • Dep. of Obstetrics and Gynecology, Bern University Hospital, Bern
        • Contact:
        • Contact:
        • Principal Investigator:
          • Petra Stute, M.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Informed consent
  • Women after Menopause (defined as 12 months of spontaneous amenorrhea or 6 months of spontaneous amenorrhea with serum FSH levels >40mlU/ml or 6 weeks postsurgical bilateral oophorectomy with or without hysterectomy)
  • Age over 18 years
  • At least 4 hot flushes per day (examined through the Menopause rating scale MRS-II)
  • No regular yoga practice for two years
  • German as native language
  • Willing to participate in 12 yoga classes as well as two 45 self practice sessions per week
  • Willing to assess biofunctional Status and give blood samples

Exclusion Criteria:

  • Acute and/or serious disease in the past two years (e.g. Cancer, major surgery)
  • Autoimmune or chronic inflammatory disease (e.g. rheumatism, thyroid dysfunction)
  • Mental illness (e.g. Depression or anxiety disorder (HADS >8))
  • Acute or chronic back pain or herniated vertebral disc
  • Compulsion to participate in the trial
  • Attendance of less than 10 yoga lessons out of 12.
  • Hormone replacement therapy (HRT)
  • Smoking > 20 Cigarettes per day or over 20 packyears
  • Consumption of >30g alcohol per day (>1 liter of beer or >0.3 dl of wine)
  • Previous periodic participation in yoga classes within the last two years
  • Inability or contraindications to undergo the investigated intervention
  • Participants incapable of judgement or participants under tutelage Diabetes mellitus

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
The intervention group receives weekly 90 minute yoga classes over a course of 12 weeks. They are also asked to do two 45-minute yoga classes at home each week and document these in a Diary.
Weekly 90 minute Iyengar Yoga classes taught y a professional instructor. Twice weekly 45 minute self practice of Iyengar Yoga at home by the participants
No Intervention: Control
The control group receives an assessment of their biofunctional status at the beginning and the end of the study (same as the intervention group).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Decrease of the biofunctional age (BFA) through a 12 week Iyengar yoga intervention compared to the control group with no yoga classes. In order to evaluate the BFA a biofunctional Status (BFS) has to be assessed.
Time Frame: 12 weeks
The BFS is a generic, age- and sex-specific test battery comprising holistic characteristics from physical, mental-emotional and social areas. The single values of the BFS test battery were scaled and differentiated for chronological age (CA) and sex. Their summation makes up the so-called Bio-functional Age Index BFAI (BFAI = Σ (B-X/B-L)n/n). The BFAI is a relative measure compared to a reference population, out of which norm charts were developed. By definition, the reference population's BFAI is identical with its CA. A BFAI of an individual may be transformed into BFA (years) by means of gerontologic aging tables. This BFA (years) relates to the mean value of a certain CA. The BFA is based on a sex-specific regression and factor analysis of functional age (Mathieu et al., 2018. Illness perception in overweight and obesity and impact on bio-functional age. Archives of gynecology and obstetrics, 298(2), p. 417)
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hot flushes
Time Frame: 12 weeks
Change of the climacteric symptom hot flushes (number per day) measured at the beginning and after 12 weeks of the intervention
12 weeks
Level of High sensitive C-reactive protein (HS-CRP)
Time Frame: 12 weeks
Change of the climacteric symptom Level of HS-CRP (mg/l) measured at the beginning and after 12 weeks of the intervention
12 weeks
Oxidative balance
Time Frame: 12 weeks
Change of the climacteric symptom oxidative balance measured at the beginning and after 12 weeks of the intervention
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Petra Stute, Prof. Dr. med, Universitätsklinik für Frauenheilkunde Bern

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2020

Primary Completion (Anticipated)

December 1, 2023

Study Completion (Anticipated)

February 1, 2024

Study Registration Dates

First Submitted

December 30, 2020

First Submitted That Met QC Criteria

January 11, 2021

First Posted (Actual)

January 12, 2021

Study Record Updates

Last Update Posted (Actual)

May 12, 2023

Last Update Submitted That Met QC Criteria

May 11, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019-01794

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Public access to the full protocol, patient dataset and statistical code will not be granted. The principal investigator will have ultimate authority over all of the activities.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postmenopausal

Clinical Trials on Iyengar Yoga

3
Subscribe